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tions, routine use remains controversial. We evaluated CIM
and compared graft patency in patients treated by surgeons
who performed routine CIM versus those who performed
selective CIM.
Methods: We reviewed the Vascular Study Group of
New England database(2003-2010) and assessed the use of
CIM(angiography and/or duplex) among patients under-
going LEB. Surgeon-specific CIM strategy was categorized
as selective(80% of LEB) versus routine(80% of LEB).
Exclusion criteria were acute limb ischemia, bilateral pro-
cedures, and surgeon volume 10 cases/study period.
Primary graft patency at discharge and 1-year were analyzed
based on CIM utilization and surgeon-specific CIM strat-
egy. Multivariable analyses were performed using Poisson
regression.
Results: Among 2032 LEB procedures performed by
48 surgeons, CIM was used in 1368 cases (67.3%). Dialysis
(OR 1.7, 95% CI 1.12-2.59, P  .01), elective LEB (OR
3.99, 95% CI 1.2-13.1, P  .02), great saphenous vein
conduit (OR 2.0, 95% CI 1.6-2.5, P  .0001), and tibial/
pedal target (OR 1.8, 95% CI 1.4-2.3, P  .0001) were
associated with CIM use. In multivariate models CIM was
not associated with improved graft patency at discharge
(OR 1.1, 95%CI: 0.7-1.7, P .64) or 1-year (OR 1.0, 95%
CI:0.8-1.4, P  .88). Sixteen surgeons(33%) were routine
and 32(67%) were selective CIM users. Discharge and
1-year graft patency was 96% versus 94% (P .21) and 68%
versus 72%(P  .09) in patients of routine versus selective
CIM users. In multivariate analysis, routine or selective
CIM strategy was not associated with improved discharge
(OR 0.8;95% CI:0.6-1.1; P  .3) or 1-year (OR 1.1; 95%
CI: 0.9-1.2; P  .56) graft patency.
Conclusions: In our observational cohort, surgeon-
specific strategy of selective CIM after LEB has comparable
outcomes with routine CIM. Use of selective rather than
routine CIM may lead to decreased health care resource
utilization.
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Objectives: Despite similar risk factors, women have
lower prevalence of PAD in the premenopausal period
compared with age-matched men. The prevalence of PAD
increases from 3-4% up to 29% in women after menopause.
By the 7th to 8th decades, the prevalence is comparable in
men and women. Little is known about the factors that
protect women from PAD prior to the onset of menopause.
The purpose of the study was to retrospectively review the
ABI and risk factor data in premenopausal ( 53 years of
age) women referred for ABI testing in the province of
Manitoba between 1993 and 2010.
Methods: In Manitoba, a province of 1.1 million,
virtually all ABI tests are performed at two hospitals by
trained technicians. Both sites also collect risk factor data.
ABI were considered to be abnormal if less than 0.9. Risk
factors included were smoking, coronary arterial disease,
obesity, diabetes, hypertension, hypercholesteremia, cere-
brovascular disease, and chronic renal failure.
Results: Between 1993 and 2010, 928 women under
the age of 53 underwent ABI testing (4.2% of all women in
the database). Of these, 260 had abnormal ABI (2.6%).
Eighty-five percent were between the ages of 41-52 and
27.9% had critically low ABI. The most prevalent risk for
premenopausal PAD in this population was current or
former smoking (85%). In most cases multiple coexisting
risk factors such as hypertension (57%), diabetes (55%), and
hyperlipidemia (55%) were present; however, no risk factor
other than smoking was present in 9.1% of women. In
premenopausal non-smokers, PAD did not develop unless
3 or more risk factors were present.
Conclusions: The development of premenopausal
PAD is unusual and does not develop without multiple
combined risk factors. Current and former smoking was
most associated with the development of premature PAD.
ABI testing in premenopausal women without multiple
combined risk factors, including smoking, is unlikely to be
of value.
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Objectives: To compare 30-day mortality and graft
failure after use of prosthetic graft (PG) versus vein graft
(VG) as conduit for extra-anatomic arterial bypass (EAB).
Methods: Patients who underwent axillary-femoral ar-
tery bypass (AFB) and femoral-femoral artery bypass (FFB)
grafts were identified from the 2007-09 National Surgical
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